Differential regulation of biosynthesis of cell surface and secreted TNF-α in LPS-stimulated murine macrophages

Journal of Leukocyte Biology

Volumn 62, Issue 2, 1997, Pages 249-257

  Chaudhri, Geeta ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cytokines; Dexamethasone; Macrophage activation; Membrane TNF

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; DEXAMETHASONE; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL SURFACE; DOSE RESPONSE; FEMALE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM EXUDATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ANIMALIA; MURINAE;

EID: 0030828460     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.62.2.249     Document Type: Article

References (45)

1. Fiers, W. (1991) Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett. 285, 199-212.
2. Aggarwal, B. B., Natarajan, K. (1996) Tumor necrosis factors: developments during the last decade. Eur. Cytokine Network 7, 93-124.
3. Kriegler, M., Perez, C., DeFay, K., Albert, I., Lu, S. D. (1988) A novel form of TNF-α/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF-α. Cell 53, 45-53.
4. Scuderi, P. (1989) Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME). J. Immunol. 143, 168-173.
5. Kim, K.-U., Kwon, O.-J., Jue, D.-M. (1993) Pro-tumour necrosis factor cleavage enzyme in macrophage membrane/particulate. Immunol. 80, 134-139.
6. Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torrance, D. S., Otten, E. C., Greenstreet, T., Weerawarna, K., Kronheim, S. R., Petersen, M., Gerhart, M., Kozlosky, C. J., March, C. J., Black, R. A. (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370, 218-220.
7. McGeehan, G. M., Becherer, J. D., Bast, R. J., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B., Nichols, J., Pryzwansky, K. M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J., Ways, J. P. (1994) Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370, 558-561.
8. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., Woolley, K. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370, 555-557.
9. Utsumi, T., Levitan, A., Hung, M. C., Klostergaard, J. (1993) Effects of truncation of human pro-tumor necrosis factor transmembrane domain on cellular targeting. J. Biol. Chem. 268, 9511-9516.
10. Utsumi, T., Akimaru, K., Kawabata, Z., Levitan, A., Tokunaga, T., Tang, P., Ide, A., Hung, M. C., Klostergaard, J. (1995) Human pro-tumor necrosis factor: molecular determinants of membrane translocation, sorting, and maturation. Mol. Cell. Biol. 15, 6398-6405.
11. Decoster, E., Vanhaesebroeck, B., Vandenabeele, P., Grooten, J., Fiers, W. (1995) Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J. Biol. Chem. 270, 18473-18478.
12. Decker, T., Lohmann-Matthes, M.-L., Gifford, G. E. (1987) Cell-associated tumor necrosis factor (TNF-α) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138, 957-962.
13. Espevik, T., Nissen, M. J. (1987) Tumour necrosis factor-like activity on paraformaldehyde-fixed monocyte monolayers. Immunology 61, 443-448.
14. Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., Scheurich, P. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumour necrosis factor receptor. Cell 83, 793-802.
15. Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L., Knegler, M. (1990) A nonsecretable cell surface mutant of tumor necrosis factor (TNF-α) kills by cell-to-cell contact. Cell 63, 251-258.
16. Ohsawa, T, Natori, S. (1989) Expression of tumor necrosis factor at a specific developmental stage of mouse embryos. Dev. Biol. 135, 459-461.
17. + T lymphocytes differ in their ability to activate macrophage antileishmanial defense. J. Leukoc. Biol. 51, 296-299.
18. + T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177, 1575-1585.
19. Tracey, K. J. (1991) Tumor necrosis factor (cachectin) in the biology of septic shock syndrome [Review]. Circ. Shock 35, 123-128.
20. Beutler, B., Cerami, A. (1986) Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320, 584-588.
21. Clark, I. A., Chaudhri, G., Cowden, W. B. (1989) Roles of tumour necrosis factor in the illness and pathology of malaria. Trans. Royal Soc. Trop. Med. Hyg. 83, 436-440.
22. Green, L. M., Reade, J. L., Ware, C. F. (1984) Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J. Immunol. Meth. 70, 257-268.
23. Austyn, J. M., Gordon, S. (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815.
24. Chomczynski, P., Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
25. Beutler, B., Krochin, N., Milsark, I. W., Luedke, C., Cerami, A. (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232, 977-980.
26. Waage, A., Bakke, O. (1988) Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63, 299-302.
27. Han, J., Thompson, P., Beutler, B. (1990) Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med. 172, 391-394.
28. Chung, I. Y., Kwon, J., Benveniste, E. N. (1992) Role of protein kinase C activity in tumor necrosis factor-alpha gene expression. Involvement at the transcriptional level. J. Immunol. 149, 3894-3902.
29. Kovacs, E. J., Radzioch, D., Young, H. A., Varesio, L. (1988) Differential inhibition of IL-1 and TNF-α mRNA expression by agents which block second messenger pathways in murine macrophages. J. Immunol. 141, 3101-3105.
30. Schade, U. F., Ernst, M., Reinke, M., Wolter, D. T. (1989) Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo. Biochem. Biophys. Res. Commun. 159, 748-754.
31. Sirko, S. P., Schindler, R., Doyle, M. J., Weisman, S. M., Dinarello, C. A. (1991) Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor. Eur. J. Immunol. 21, 243-250.
32. Peters, S. P., MacGlashan, D. W., Jr., Schleimer, R. P., Hayes, E. C., Adkinson, N. F., Jr., Lichtenstein, L. M. (1985) The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells. Am. Rev. Respir. Dis. 132, 367-373.
33. Kuhn, H., Schewe, T., Rapoport, S. M. (1984) The inactivation of lipoxygenases by acetylenic fatty acids. Biomed. Biochim. Acta 43, S358-S361.
34. Hidaka, H., Inagaki, M., Kawamoto, S., Sasaki, Y. (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochem. 23, 5036-5041.
35. Lentz, D. J., Henderson, G. H., Eyring, E. M. (1973) Kinetics of aqueous iron(3) complexation by desferrioxamine B. Mol. Pharmacol. 9, 514-519.
36. Remick, D. G., Strieter, R. M., Lynch, J. D., Nguyen, D., Eskandari, M., Kunkel, S. L. (1989) In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab. Invest. 60, 766-771.
37. Beutler, B. (1990) Regulation of cachectin biosynthesis occurs at multiple levels. Prog. Clin. Biol. Res. 349, 229-240.
38. Schook, L. B., Albrecht, H., Gallay, P., Jongeneel, C. V. (1994) Cytokine regulation of TNF-α mRNA and protein production by unprimed macrophages from C57Bl/6 and NZW mice. J. Leukoc. Biol. 56, 514-520.
39. Han, J., Beutler, B. (1990) The essential role of the UA-rich sequence in endotoxin-induced cachectin/TNF-α synthesis. Eur. Cytokine Netw. 1, 71-75.
40. Pradines-Figueres, A., Raetz, C. R. (1992) Processing and secretion of tumor necrosis factor alpha in endotoxin-treated Mono Mac 6 cells are dependent on phorbol myristate acetate. J. Biol. Chem. 267, 23261-23268.
41. Tanabe, Y., Kitahara-Tanabe, N., Mizuno, D., Soma, G. I. (1994) Enhanced production of tumour necrosis factor alpha (TNF-α) by its precursor on the cell surface of primed THP-1 cells. Cytokine 6, 337-348.
42. Niehorster, M., Tiegs, G., Schade, U. F., Wendel, A. (1990) In vivo evidence for protease-catalysed mechanism providing bioactive tumor necrosis factor alpha. Biochem. Pharmacol. 40, 1601-1603.
43. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., Cerretti, D. P. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733.
44. Moss, M. L., Jin, S. L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J. L., Warner, J., Willard, D., Becherer, D. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733-736.
45. Pocsik, E., Duda, E., Wallach, D. (1995) Phosphorylation of the 26kDa TNF-α precursor in monocytic cells and in transfected HeLa cells. J. Inflam. 45, 152-160.